Invivyd financials
$0.8501−10.52%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $53.4M | $25.4M | $0.00 | $0.00 |
| Gross profit | $49.7M | $23.8M | $0.00 | $0.00 |
| Gross margin | 93.0% | 93.6% | — | — |
| Operating income | -$55.6M | -$176.9M | -$212.8M | -$230.7M |
| Net income | -$52.5M | -$169.9M | -$198.6M | -$241.3M |
| Net margin | −98.2% | −669.4% | — | — |
| Diluted EPS | $-0.30 | $-1.43 | $-1.81 | $-2.23 |
| EBITDA | -$54.8M | -$175.4M | -$212.3M | -$230.2M |
| Operating cash flow | -$58.1M | -$170.5M | -$173.2M | -$220.0M |
| Free cash flow | -$58.3M | -$170.6M | -$173.8M | -$221.7M |
| Diluted shares | 172.2M | 118.6M | 109.5M | 108.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $226.7M | $69.3M | $200.6M | $92.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $279.9M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $276.9M | $129.5M | $229.2M | $383.2M |
| Total liabilities | $35.3M | $62.0M | $51.7M | $27.2M |
| Shareholders' equity | $241.5M | $67.5M | $177.5M | $356.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology